Get started
Author

Hana Cechova

Observed names: H. CECHOVA, H. Cechova, H. Čechová
ORCID: 0000-0003-0539-8575
Observed ORCID: 0000-0003-0539-8575
OpenAlex ID: A5065759166
Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia
2011 · H. CECHOVA, P. LASSUTHOVA, et al. · Neoplasma · 29
PDF
Quantitative monitoring of WT1 expression in peripheral blood before and after allogeneic stem cell transplantation for acute myeloid leukemia – a useful tool for early detection of minimal residual disease
2012 · J. POLAK, H. HAJKOVA, et al. · Neoplasma · 23
PDF
WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML – A Single-center 14-year Experience
2020 · Veronika Valkova, Jan Vydra, et al. · Clinical Lymphoma Myeloma & Leukemia · 9
Chimerism as an important marker in post‐transplant monitoring chimerism monitoring
2018 · Hana Cechova, Monika Leontovycova, et al. · HLA · 9
Genetic and epigenetic characterization of low‐grade gliomas reveals frequent methylation of the M LH3gene
2015 · Halka Lhotska, Zuzana Zemanova, et al. · Genes Chromosomes and Cancer · 9
Circulating Endothelial Precursor Cells (EPC) in Patients Undergoing Allogeneic Haematopoietic Progenitor Cell Transplantation
2010 · Robert Pytlík, L. Kideryová, et al. · Folia Biologica · 5
PDF
Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy
2023 · Pavla Taborska, Pavol Lukac, et al. · Scientific Reports · 4
PDF
Multiplex real‐time quantitative polymerase chain reaction assay for rapid and sensitive detection of hematopoietic chimerism
2018 · Sylvie Nadvornikova, Monika Leontovycova, et al. · HLA · 4
Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients
2025 · Halka Lhotska, Karolina Janeckova, et al. · Clinical Epigenetics · 1
PDF
Evolution of genomic profiles in primary and recurrent brain gliomas.
2023 · Libuse Lizcova, Denisa Vidlakova, et al. · Journal of Clinical Oncology
PDF
Suitable Molecular Genetic Methods for the Monitoring of Cell Chimerism
2019 · Hana Cechova, Lucie Pavlatova, et al. · IntechOpen eBooks
PDF
Comparison of genomic profiles to reveal heterogenous patterns of tumor evolution in primary and recurrent diffuse gliomas.
2018 · Libuse Lizcova, Karla Svobodova, et al. · Journal of Clinical Oncology
Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations
2016 · Halka Lhotska, Zuzana Zemanova, et al. · Molecular Cytogenetics
PDF
HVRII of mtDNA in Cord Blood Cells of Newborn Children and in Their Saliva 10 Years Later
2011 · J. Schmuczerová, P. Tőrőková, et al. · Folia Biologica
PDF
C011 Gene methylation, telomere length and activity of telomerase reflect the disease activity in MDS patients and may help to assess an individual risk of patients
2009 · H. Cechova, R. Stemberkova, et al. · Leukemia Research
P047 Determining of intensity methylation in the area of promoter gene P15INK4B as prognostic marker in patients with myelodysplastic syndromes (MDS)
2009 · H. Cechova, R. Stemberkova, et al. · Leukemia Research
Can Gene Methylation, Telomere Length and Activity of Telomerase Help with Individual Risk and Treatment Strategy of MDS Patients?
2008 · Hana Cechova, Sona Vcelikova, et al. · Blood
Works count: 17
Citation count: 93
H-index: 5
I10-index: 2
Year
Topic
Type